Travere Therapeutics Quote - TVTX

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

20.31

Bid

20.32

Ask

20.95

Volume

1,266,673

20.26 Day's Range 21.56

5.12 52 Week Range 20.33

Market Cap

1.585B

Previous Close

20.81

Open

20.96

Last Trade

20.33

Last Trade Time

Financial Volume

US$ 26,362,004

VWAP

20.812

Average Volume (3m)

1,299,239

Shares Outstanding

78,049,928

Dividend Yield

PE Ratio

-14.22

Earnings Per Share (EPS)

-1.43

Revenue

145.24M

Net Profit

-111.4M

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

travere.com

Headquarters

Lewes, Delaware, USA

Founded

Travere Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TVTX. The last closing price for Travere Therapeutics was US$20.81. Over the last year, Travere Therapeutics shares have traded in a share price range of US$ 5.12 to US$ 20.33.

Travere Therapeutics currently has 78,049,928 shares outstanding. The market capitalization of Travere Therapeutics is US$1.62 billion. Travere Therapeutics has a price to earnings ratio (PE ratio) of -14.22.

Overall Flow

Bullish

Net Premium

511k

Calls / Puts

150,00%

Buys / Sells

150,00%

OTM / ITM

400,00%

Sweeps Ratio

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.77	9.54692556634	18.54	20.31	18.24	1565713	19.2598902	CS
4	2.66	15.0708215297	17.65	20.31	16.8	1181188	18.50941734	CS
12	2.36	13.147632312	17.95	20.33	16.588	1299239	18.2724419	CS
26	10.68	110.903426791	9.63	20.33	7.931	1529228	15.35537757	CS
52	10.88	115.376458112	9.43	20.33	5.12	1355234	11.9858479	CS
156	-4.87	-19.3407466243	25.18	30.35	5.12	1220555	15.31638045	CS
260	-4.84	-19.2445328032	25.15	33.0899	5.12	1086629	16.64282583	CS

TVTX - Frequently Asked Questions (FAQ)

What is the current Travere Therapeutics share price?

The current share price of Travere Therapeutics is US$ 20.31

How many Travere Therapeutics shares are in issue?

Travere Therapeutics has 78,049,928 shares in issue

What is the market cap of Travere Therapeutics?

The market capitalisation of Travere Therapeutics is USD 1.62B

What is the 1 year trading range for Travere Therapeutics share price?

Travere Therapeutics has traded in the range of US$ 5.12 to US$ 20.33 during the past year

What is the PE ratio of Travere Therapeutics?

The price to earnings ratio of Travere Therapeutics is -14.22

What is the cash to sales ratio of Travere Therapeutics?

The cash to sales ratio of Travere Therapeutics is 10.9

What is the reporting currency for Travere Therapeutics?

Travere Therapeutics reports financial results in USD

What is the latest annual turnover for Travere Therapeutics?

The latest annual turnover of Travere Therapeutics is USD 145.24M

What is the latest annual profit for Travere Therapeutics?

The latest annual profit of Travere Therapeutics is USD -111.4M

What is the registered address of Travere Therapeutics?

The registered address for Travere Therapeutics is 16192 COASTAL HWY, LEWES, DELAWARE, 19958

What is the Travere Therapeutics website address?

The website address for Travere Therapeutics is travere.com

Which industry sector does Travere Therapeutics operate in?

Travere Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NVNINVNI Group Ltd	US$ 4.38 (193.96%)	366.98M
EVAXEvaxion Biotech AS	US$ 5.99 (64.56%)	55.41M
ELABPMGC Holdings Inc	US$ 3.0901 (56.07%)	76.48M
PCLAPicoCELA Inc	US$ 4.60 (49.35%)	3.75M
GOEVCanoo Inc	US$ 0.475 (43.94%)	282.22M
GODNUGolden Star Acquisition Corporation	US$ 3.11 (-75.82%)	17.51k
GODNGolden Star Acquisition Corporation	US$ 2.93 (-65.67%)	902.76k
NXTTNext Technology Holding Inc	US$ 1.37 (-54.93%)	2.56M
SGLYSingularity Future Technology Ltd	US$ 1.625 (-38.45%)	917.77k
WHLRLWheeler Real Estate Investment Trust Inc	US$ 90.11 (-38.07%)	8
ACONAclarion Inc	US$ 0.0557 (28.94%)	811.91M
NVNINVNI Group Ltd	US$ 4.38 (193.96%)	366.98M
RIMEAlgorhythm Holdings Inc	US$ 0.0357 (4.69%)	284.97M
GOEVCanoo Inc	US$ 0.475 (43.94%)	282.22M
NVDANVIDIA Corporation	US$ 142.62 (-3.12%)	232.88M